Arrowhead’s gene silencer competitive with Ionis’ in triglyceride disease

Look out Ionis, here comes Arrowhead with promising hypertriglyceridemia data

Less than a month after Ionis Pharmaceuticals scored an FDA expansion for Tryngolza to become t | Less than a month after Ionis scored an FDA expansion for Tryngolza to become the first drug to specifically treat severe…